China's Sinovac Cuts Risk Of Symptomatic Covid But 50% Effective: Study
Sinovac Biotech Ltd.'s coronavirus vaccine cut in half the risk of developing symptomatic Covid-19 in a key Brazilian study, suggesting two doses of the shot is less potent than some other...
No comments:
Post a Comment